Tetravisc Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudy
or discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to be
used more frequently, creating a "vicious circle". Subsequent corneal infection and/or corneal opacification with accompanying
permanent visual loss or corneal perforation may occur. Prolonged use may also produce severe keratitis.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


For procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy,
removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva,
other short corneal and conjunctival procedures.


There is currently no drug history available for this drug.

Other Information

Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye. The
active ingredient is represented by the structural formula:

CH 3(CH 2)3NH      COOCH2CH2N(CH3)2.HCI

Tetravisc Manufacturers

  • Ocusoft, Inc.
    Tetravisc (Tetracaine Hydrochloride) Liquid [Ocusoft, Inc.]

Login To Your Free Account